Company intelligence / Profile preview
Servatus Biopharmaceuticals
Coolum Beach, Queensland, Australiaservatus.com.au ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Phase 1
01
Overview
Servatus has achieved key clinical milestones indicating potential to change treatment paradigms for severe autoimmune diseases. The company has reported positive results in early clinical studies for insomnia and IBS-C. Its LBP program includes a Phase I trial for H. pylori infection and Phase II trials in autoimmune/inflammatory conditions. The company also produces OTC microbiome-based products targeting skin health and GI symptoms.
- Therapeutic areas
- GastroenterologyPsychiatryImmunologyInfectious Diseases
- Modalities
- Live biotherapeutic products (LBPs)Engineered/modified proteins
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Partnered with a multinational pharmaceutical organization to fund manufacturing expansionJoint venture with Australian Biotherapeutics on manufacturing technology acquisition
Beyond the preview
Go deeper on Servatus Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Servatus Biopharmaceuticals.